The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2018 FNIH Trailblazer Prize for Clinician-Scientists Nomination Deadline: March 30

2018 FNIH Trailblazer Prize for Clinician-Scientists Nomination Deadline: March 30

March 12, 2018 • By Foundation for the National Institutes of Health

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In 2018, the Foundation for the National Institutes of Health (FNIH) will present the FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), which recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care. This $10,000 honorarium and prize celebrates the achievements of medical doctors whose research has translated basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability. The prize, made possible by an anonymous donation, will be presented at the FNIH Annual Fall Board Dinner on Oct. 24, 2018, in Washington, D.C.

You Might Also Like
  • New Lupus Insight Prize Aims to Advance Lupus Research
  • Immunology Research Pioneers Receive Carol Nachman Prize
  • Time to Get Involved with ARHP

The FNIH recognizes the unique and critical role that clinician-scientists play in the evolution of medical practice. As noted in the 2014 NIH Physician-Scientist Workforce Report, these individuals play a vital role in ensuring that biomedical advances ultimately benefit patients and improve population health. Through the Trailblazer Prize, the FNIH celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The awardee will be selected by a jury of distinguished clinical-scientists including:

  • Steven M. Paul, M.D., (Jury Chair), President and Chief Executive Officer, Voyager Therapeutics, Inc., Venture Partner at Third Rock Ventures
  • Barry Coller, M.D., David Rockefeller Professor of Medicine, Head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, Physician-in-Chief of the Rockefeller University Hospital, Vice President for Medical Affairs, The Rockefeller University
  • Helen H. Hobbs, M.D., Investigator, Howard Hughes Medical Institute and Professor of Internal Medicine and Molecular Genetics, University of Texas Southwestern Medical Center
  • John I. Gallin, M.D., NIH Associate Director for Clinical Research and Chief Scientific Officer of the NIH Clinical Center
  • Michael J. Welsh, M.D., Director, Pappajohn Biomedical Institute, University of Iowa

Nominators and/or candidates must not contact any member of the Trailblazer Prize jury to ask about or discuss any aspect of the prize. If this occurs, that nomination will be withdrawn from the competition.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Eligibility Criteria:

  • Candidate must be a practicing clinician with at least 50% of time devoted to independent active research efforts.
  • Candidate must hold a full-time primary appointment as instructor, assistant professor or be an early-career staff member of a clinical department or unit.
  • Candidate is nominated for an achievement(s) in basic, translational and/or clinical research leading to new, innovative approaches in the diagnosis, prevention, treatment or cure of diseases and/or disabilities.
  • Two early career researchers may be nominated if they have worked as a team; in this case, at least one of the two must be a clinician-scientist as defined in the first two eligibility bullets above. When the Trailblazer Prize is given to two individuals, the honorarium will be divided among the winners and each will receive a citation and an inscribed crystal award.
  • Candidate must be a legal resident of the United States or a U.S. territory.

Nomination Criteria:

  • Nominations are broadly solicited and can be made by any member of an accredited educational and/or scientific institution. There is no limitation on the number of nominations that may be made by a single nominator or institution. No institutional approval is required.
  • No self-nominations will be accepted.
  • Nominations are to be for outstanding early career clinician-scientists who reside in the United States. The prize will recognize an individual or a team of two early career individuals, one of whom must meet the Eligibility Criteria.
  • Nomination materials must be in English.
  • If candidates are U.S. federal government employees or anyone else whose receipt of personal cash prizes may be restricted, the nominator should confirm with the candidate that he or she is eligible to receive this prize.
  • Nominations of women and minorities are encouraged.

Nominations must include the following information:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  • The candidates’ name, title, institution, birth date, earned degrees and contact information (mailing address, telephone number, e-mail address).
  • The nominator’s name, title, institution, terminal degree(s) and contact information (mailing address, telephone number, e-mail address).
  • A brief explanation of how the candidate(s) fit the eligibility criteria.
  • A 50-word citation of the basis for nomination.
  • A 250-word description of the candidates’ contributions.
  • The candidates’ curriculum vitae (CV), including no more than 10 citations of publications on which the nomination is based. Nominations submitted with CVs listing more than 10 publications will be rejected.
  • Up to three brief letters of support that specifically address the nominees’ accomplishments are encouraged. The letters must be submitted with the online nomination rather than separately; letters submitted through another mechanism (e.g., email) will not be considered during the review process.

The nomination deadline is March 30, 2018, 1:00 PM EDT. Submit a Nomination for: 1 Candidate | Team of 2 Candidates.

Pages: 1 2 | Single Page

Filed Under: Awards, Professional Topics Tagged With: Awards, Foundation for the National Institutes of Health, National Institutes of Health (NIH), Trailblazer Prize

You Might Also Like:
  • New Lupus Insight Prize Aims to Advance Lupus Research
  • Immunology Research Pioneers Receive Carol Nachman Prize
  • Time to Get Involved with ARHP
  • Mark Shlomchik Awarded Inaugural Lupus Insight Prize

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)